Delivery Order SPE2DR25D1034-SPE2DR26FPW9A
- Not listed
- AmerisourceBergen Drug Corp was awarded a $1,156.08 delivery order by the Defense Logistics Agency (DLA) for 100 capsules of Adderall XR 20 mg. This contract represents a non-set-aside, competitively awarded delivery order issued under firm fixed pricing with a completion date of December 2, 2025. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Adderall XR 20 mg capsules. The contract has a potential value of $1,035.61 and a performance period through March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order, which is part of a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $2,508.14. This non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is scheduled for completion by...
- Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., has been awarded a $1,339.95 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide Adderall XR 20 mg capsules. This order falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
- The Defense Logistics Agency awarded a delivery order valued at $1,290.28 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,097.69. This non-set-aside delivery order is scheduled for completion by December 10, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of the company's extensive role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $2,862.68. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Adderall XR 20 mg capsules in quantities of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,586.45 under a firm fixed-price delivery order arrangement, with an ultimate completion date of December 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to supply Adderall XR 10 mg capsules. The contract has a completion date of January 31, 2024 and a potential value of $2,308.56. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Adderall XR 20 mg capsules. The contract has a ceiling value of $3,666.20 and a performance period through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPW9ADelivery Order
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency (DLA) on January 6, 2026, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,177.36. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for ultimate completion on January 7, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitively awarded task order under AmerisourceBergen's existing pharmaceutical supply relationship with DLA. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical commodities to support military healthcare programs globally. The IDC encompasses a wide range of products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, enabling AmerisourceBergen to efficiently fulfill essential pharmaceutical requirements for military treatment facilities, the Defense Health Agency, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/5/26 |